Emmes
The Industry’s First Native Digital and AI Specialty CRO
Advancing human health with scientific rigor and integrity
Welcome to Emmes, a full-service clinical research organization (CRO) dedicated to helping biopharmaceutical, government, non-profit and academic partners achieve their development and human health goals.
Specialties
Emmes’ specialties covers a broad range of therapeutic areas with a particular focus on Vaccines and Infectious Diseases, Ophthalmology, Neuroscience, Cell and Gene Therapy, and Rare Disease.
Emmes Group Brands
Emmes Group is a global contract research organization advancing health innovation through a network of specialized brands. With deep roots in public-sector research and a growing presence in the biopharma industry, we integrate scientific rigor, operational excellence, and technology-driven solutions to accelerate the development of safe, effective treatments.
Your Next Steps
Insider Tips for a Successful Application
At Emmes Group, we believe in making the application process as straightforward and supportive as possible. Here’s how to set yourself up for success when applying to join our team:
Why Join Us
Your Career, Your Impact:
5 Reasons to Join Emmes Group
At Emmes Group, we don’t just conduct clinical research—we drive breakthroughs that improve lives worldwide. If you’re looking for a career with purpose, innovation, and growth, here’s why you belong here:
Life at Emmes Group
Our Culture: Living our values every day
Our culture at Emmes Group is more than just words— it’s how we work, grow, and thrive together. We believe that when talented people share a purpose, embrace innovation, and support one another, incredible things happen.
Clinical Services
When we work together, we can achieve better. Everything you need to
succeed is already here: uniquely expert clinical research professionals,
advanced and advancing technologies, decades of global clinical research.
Our skill sets, technologies and breadth of services can capably manage
any clinical study. The real difference? How we embrace your goals and
manage your study as if it were our own, whether you partner with us as
Rare Disease Day: Emmes Endpoints Solutions submits Duchenne video assessment qualification plan to FDA
Go back to Newsroom
Rare Disease Day: Emmes Endpoints Solutions submits Duchenne video assessment qualification plan to FDA